Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
40
pubmed:dateCreated
2002-9-30
pubmed:abstractText
Cyclic AMP potentiates glucose-stimulated insulin release and mediates the stimulatory effects of hormones such as glucagon-like peptide 1 (GLP-1) on pancreatic beta-cells. By inhibition of cAMP-degrading phosphodiesterase (PDE) and, in particular, selective inhibition of PDE3 activity, stimulatory effects on insulin secretion have been observed. Molecular and functional information on beta-cell PDE3 is, however, scarce. To provide such information, we have studied the specific effects of the PDE3B isoform by adenovirus-mediated overexpression. In rat islets and rat insulinoma cells, approximate 10-fold overexpression of PDE3B was accompanied by a 6-8-fold increase in membrane-associated PDE3B activity. The cAMP concentration was significantly lowered in transduced cells (INS-1(832/13)), and insulin secretion in response to stimulation with high glucose (11.1 mm) was reduced by 40% (islets) and 50% (INS-1). Further, the ability of GLP-1 (100 nm) to augment glucose-stimulated insulin secretion was inhibited by approximately 30% (islets) and 70% (INS-1). Accordingly, when stimulating with cAMP, a substantial decrease (65%) in exocytotic capacity was demonstrated in patch-clamped single beta-cells. In untransduced insulinoma cells, application of the PDE3-selective inhibitor OPC3911 (10 microm) was shown to increase glucose-stimulated insulin release as well as cAMP-enhanced exocytosis. The findings suggest a significant role of PDE3B as an important regulator of insulin secretory processes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
4
pubmed:volume
277
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
37446-55
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12169692-3',5'-Cyclic-AMP Phosphodiesterases, pubmed-meshheading:12169692-Animals, pubmed-meshheading:12169692-Base Sequence, pubmed-meshheading:12169692-Cells, Cultured, pubmed-meshheading:12169692-Cyclic AMP, pubmed-meshheading:12169692-Cyclic Nucleotide Phosphodiesterases, Type 3, pubmed-meshheading:12169692-DNA Primers, pubmed-meshheading:12169692-Exocytosis, pubmed-meshheading:12169692-Glucose, pubmed-meshheading:12169692-Insulin, pubmed-meshheading:12169692-Insulinoma, pubmed-meshheading:12169692-Islets of Langerhans, pubmed-meshheading:12169692-Kinetics, pubmed-meshheading:12169692-Male, pubmed-meshheading:12169692-Pancreatic Neoplasms, pubmed-meshheading:12169692-Rats, pubmed-meshheading:12169692-Rats, Sprague-Dawley, pubmed-meshheading:12169692-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:12169692-Tumor Cells, Cultured
pubmed:year
2002
pubmed:articleTitle
Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin.
pubmed:affiliation
Department of Cell and Molecular Biology, Biomedical Centre, C11, Lund University, SE-221 84 Lund, Sweden. Linda.Harndahl@medkem.lu.se
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't